The ROE as of September 2024 (TTM) for Silence Therapeutics plc (SLN) is -58.66%

According to Silence Therapeutics plc’s latest financial reports and current stock price. The company's current ROE is -58.66%. This represents a change of 66.25% compared to the average of -35.28% of the last 4 quarters.

Silence Therapeutics plc (SLN) Historical ROE (quarterly & annually)

How has SLN ROE performed in the past?

The mean historical ROE of Silence Therapeutics plc over the last ten years is -147.45%. The current -58.66% ROE has changed -60.22% with respect to the historical average. Over the past ten years (40 quarters), SLN's ROE was at its highest in in the June 2022 quarter at 251.88%. The ROE was at its lowest in in the March 2022 quarter at -192.58%.

Silence Therapeutics plc (SLN) ROE by Quarter and Year

Discovering the peaks and valleys of Silence Therapeutics plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Silence Therapeutics plc (SLN) Average ROE

How has SLN ROE performed in the past?

The current ROE of Silence Therapeutics plc (SLN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Silence Therapeutics plc (SLN) ROE vs. Peers

How is SLN’s ROE compared to its peers?

Silence Therapeutics plc’s ROE is greater than Cidara Therapeutics, Inc. (-401.89%), greater than Applied Therapeutics, Inc. (-577.92%), greater than CytomX Therapeutics, Inc. (-27.44%), less than Shattuck Labs, Inc. (0%), greater than C4 Therapeutics, Inc. (-68.65%), greater than Eliem Therapeutics, Inc. (-44.60%), greater than Prelude Therapeutics Incorporated (-47.03%), greater than Monte Rosa Therapeutics, Inc. (-59.82%), greater than Opthea Limited (-70.40%), less than Centessa Pharmaceuticals plc (360.05%), greater than Nuvalent, Inc. (-63.22%), greater than Tarsus Pharmaceuticals, Inc. (-28.83%), greater than Genfit S.A. (-63.99%), greater than Avidity Biosciences, Inc. (-60.96%), greater than IGM Biosciences, Inc. (-32.89%), greater than Cerevel Therapeutics Holdings, Inc. (-119.02%), greater than Cullinan Oncology, Inc. (-98.94%), greater than Mineralys Therapeutics, Inc. (-28.37%), greater than null (-42.61%),

Build a custom stock screener for Silence Therapeutics plc (SLN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Silence Therapeutics plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Silence Therapeutics plc (SLN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Silence Therapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.